SCHEDULE 13D

Company

ROCKET PHARMACEUTICALS, INC.

Filed

March 5, 2015

Accession Number

0000929638-15-000310

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →